|
What is it?
A liver disease caused by the hepatitis A virus.
Clinical Features:
Jaundice
(yellowing of skin and eyes); fatigue; abdominal pain, loss of appetite, intermittent nausea, diarrhea
Transmission: Fecal-oral; food/waterborne outbreaks;
blood borne (rare)
Risk Groups:
-
Household/sexual contact with infected
persons
-
International travelers
-
Persons living in American Indian reservations,
Alaska Native villages,and other regions with endemic Hepatitis A.
Prevention:
-
Hepatitis A vaccine is highly effective
in preventing Hepatitis A.
-
Immune globulin given pre- and post-exposure can prevent
infection
-
Good hygiene and sanitation
|
What is it?
A serious disease caused by a
virus that attacks the liver. It can cause lifelong infection, cirrhosis (scarring) of the
liver, liver cancer, liver failure, and death.
The Hepatitis B vaccination is available for all age
groups to prevent Hepatitis B virus infection. For more information
about the vaccine call: 454-4645
Clinical Features:
Jaundice
(yellowing of skin and eyes); fatigue; abdominal pain, loss of appetite, intermittent nausea, vomiting
How do people get it?
Who is at risk?
-
Injection drug users (IDUs)
-
Sexually active heterosexuals
-
Men who have sex with men
-
Infants and children of immigrants from disease-endemic
areas
-
Sexual/household contact with infected persons
-
Babies born to infected mothers
-
Health care workers
-
Hemodialysis patients
Prevention:
-
Hepatitis B vaccine available since 1982
-
Screening of pregnant women and treatment of
babies born to infected women
-
Routine vaccination of 0-18 year olds
-
Vaccination for high risk individuals of all ages
-
Screening of blood/organ/tissue donors
|
What is it?
A disease of the liver caused
by the hepatitis C virus. (According to the CDC) You may be at risk for
hepatitis C and should contact your medical care provider for a blood
test if you:
-
Have ever injected illegal drugs, even if you experimented
a few times many years ago
-
Received a blood transfusion or solid organ
transplant before July, 1992
-
Received a blood product for clotting problems
produced before 1987
-
Have ever been on long-term kidney dialysis
-
Have evidence of liver disease
Clinical Features:
Jaundice
(yellowing of skin and eyes); fatigue; abdominal pain, loss of appetite, intermittent nausea, vomiting
How do people get it?
Primarily bloodborne; also
sexually transmitted and perinatal
Who is at risk?
-
Injection drug users
-
Hemodialysis patients
-
Health care workers
-
Sexual partners of infected persons
-
Persons with multiple sex partners
-
Recipients of blood transfusions before July
1993
-
Recipients of clotting factors made before 1987
-
Babies born to infected women
Prevention:
|
